Company / Current Liabilities
Senti Biosciences Holdings, Inc. Current Liabilities History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$14.0M
FY2025
5-year range
$12.7M / $18.1M
FY2022-FY2025
Trend
+6.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $13M to $14M over the past 2 years.
Based on SEC 10-K filings.
$14M in FY2025 with a 3-year CAGR of -8.2%.
Increased from $13M to $14M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -8.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -8.2%, indicating a declining trend.
- In FY2025, current liabilities increased 6.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.0M | +6.3% |
| FY2024 | $13.1M | +3.7% |
| FY2023 | $12.7M | -29.8% |
| FY2022 | $18.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026